Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ERIS stock hub

NSE/ERIS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ERISis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

192B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ERIS

In the news

Latest news · NSE/ERIS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.7

P25 24.9P50 32.4P75 45.7

Trailing P/E43.8

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC10.8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ERIS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

INR

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,354
Employees Change	-266%
Employees Change Percent	-7.35
Enterprise value	INR 219.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE406M01024
Last refreshed	2026-05-10
Market cap	INR 192B
Price	INR 1,396
Price currency	INR
Rev Per Employee	9,138,938.58x
Sector	Healthcare
Sic	2834
Symbol	nse/ERIS
Website	https://www.eris.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.24%
EV Earnings	50.88x
EV/EBIT	26.98x
EV/EBITDA	17.89x
EV/Sales	7.15x
Forward P/E	29.66x
P/B ratio	5.48x
P/E ratio	43.83x
P/S ratio	6.26x
PE Ratio10 Y	31.67x
PE Ratio3 Y	41.39x
PE Ratio5 Y	34.57x
PEG ratio	0.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.48%
EBITDA Margin	39.61%
Gross margin	73.91%
Gross Profit	INR 22.7B
Gross Profit Growth	10.74%
Gross Profit Growth Q	5.93%
Gross Profit Growth3 Y	22.93%
Gross Profit Growth5 Y	19.14%
Net Income	INR 4.3B
Net Income Growth	30.87%
Net Income Growth Q	19.24%
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Net Income Growth3 Y	2.78%
Net Income Growth5 Y	4.67%
Pretax Margin	19.8%
Profit Margin	14.06%
Profit Per Employee	INR 1.3M
Profitable Years	14
Roa5y	9.62
Roe5y	18.45
ROIC	10.81
Roic5y	17.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.82%
Cagr3y	30.91%
Cagr5y	17.42%
Div CAGR3	0%
EPS Growth	30.8
EPS Growth Q	19.06
EPS Growth Quarters	4
EPS Growth Years	0
EPS Growth3 Y	2.71
EPS Growth5 Y	4.62
Revenue Growth	12.53x
Revenue Growth Q	10.91x
Revenue Growth Quarters	27x
Revenue Growth Years	13x
Revenue Growth3 Y	25.08x
Revenue Growth5 Y	21.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 747.5M
Debt	INR 23.9B
Debt EBITDA	INR 1.95
Debt Equity	INR 0.68
Equity	INR 35B
Interest Coverage	4.03
Net Cash	INR -23.1B
Net Cash By Market Cap	INR -12.05
Net Debt EBITDA	INR 1.91
Net Debt Equity	INR 0.66
Tangible Book Value	INR -14.5B
Tangible Book Value Per Share	INR -106
WACC	3.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth Years	0%
Dividend per share	INR 7.35
Dividend Years	1
Dividend Yield	0.53%
Last Dividend	INR 7.35

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.82%
200-day SMA	1,539
3Y total return	124.41%
50-day SMA	1,351.2
50-day SMA vs 200-day SMA	50under200
5Y total return	123.15%
All Time High	1,910
All Time High Change	-26.9%
All Time High Date	2025-06-12
All Time Low	321
All Time Low Change	334.95%
All Time Low Date	2020-03-13
ATR	48.28
Beta	-0.12
Beta1y	-0.18
Beta2y	-0.04
Ch YTD	-7.27
High	1,410
High52	1,910
High52 Date	2025-06-12
High52ch	-26.9%
Low	1,381.6
Low52	1,200
Low52 Date	2026-04-28
Low52ch	16.35%
Ma50ch	3.33%
Price vs 200-day SMA	-9.28%
RSI	54.51
RSI Monthly	52.88
RSI Weekly	44.69
Sharpe ratio	-0.24x
Sortino ratio	-0.15
Total Return	0.5%
Tr YTD	-7.27
Tr1m	6.14%
Tr1w	3.15%
Tr3m	-2.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 8.1B
Operating Income Growth	30.09
Operating Income Growth Q	24.93
Operating Income Growth3 Y	24.68
Operating Income Growth5 Y	16.94
Operating margin	26.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,161,469%
Shares Insiders	59.49%
Shares Institutions	20.7%
Shares Out	138,542,887
Shares Qo Q	-0.01%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	137,658.45x
Bv Per Share	226.8
Ch1m	6.14
Ch1w	3.15
Ch1y	-4.82
Ch3m	-2.43
Ch3y	123.1
Ch5y	117.8
Ch6m	-12.42
Change	0.94%
Change From Open	0.95
Close	1,383.2
Days Gap	-0.01
Depreciation Amortization	4,025,800,000
Dollar Volume	69,491,666.4
Earnings Date	2026-05-19
EBIT	INR 8.1B
EBITDA	INR 12.1B
EPS	INR 31.63
F Score	1
Fiscal Year End	March
Founded	2,007
Graham Number	401.76974
Graham Upside	-71.22
Income Tax	INR 1.4B
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Lynch Fair Value	INR 158
Lynch Upside	-88.67
Ma150	1,473.6
Ma150ch	-5.25%
Ma20	1,379.8
Ma20ch	1.19%
Next Earnings Date	2026-05-19
Open	1,383
Payment Date	2025-03-09
Position In Range	51.41
Price Date	2026-05-08
Price EBITDA	INR 15.82
Relative Volume	0.36x
Revenue	30,652,000,000x
Tax By Revenue	4.46x
Tax Rate	22.55%
Tr6m	-12.42%
Volume	49,772

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ERIS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$7.35 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.5%

Dividend yield + buyback yield combined

Performance

NSE/ERIS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ERIS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.7%

Share of float held by funds and institutions

Insider ownership

+59.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/ERIS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.5

Neutral momentum band

Price vs 200-day MA

-9.3%

50/200-day relationship not available

Beta (5Y)

-0.12

Less volatile than the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ERIS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ERIS stock rating?

nse/ERIS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ERIS analysis?

The full report lives at /stocks/nse/ERIS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ERIS?

The latest report frames nse/ERIS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ERIS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.